ABPI response to first COVID-19 vaccine approval

02 December 2020 Posted in News by Press Office

The first vaccine for COVID-19 has been approved for use by the UK's independent regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA) today. 

In response to the news, ABPI Chief Executive Dr Richard Torbett said: 

“Today’s approval for the Pfizer / BioNtech vaccine in the UK is great news and another milestone in the fight against COVID-19.

"That people in the UK will be among the first to be offered a vaccine is a testament to the timely and dedicated work of our world-class health regulator, the MHRA.

"With a number of new vaccines on the horizon, it’s exciting to see that the scientific partnerships forged earlier in the year may finally be starting to lead us out of this pandemic.”

TAGS
  • COVID 19

Last modified: 20 September 2023

Last reviewed: 20 September 2023

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.

Media enquiries

+44 (0) 20 7747 7147​​